Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration

The volume of prescription drug promotion over time is often measured by assessing changes in ad spending. However, this method obscures the fact that some types of advertising are more expensive than others. Another way to measure the changes in prescription drug promotion over time is to assess th...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2016-05, Vol.11 (5), p.e0155035-e0155035
Main Authors: Sullivan, Helen W, Aikin, Kathryn J, Chung-Davies, Eunice, Wade, Michael
Format: Article
Language:English
Subjects:
Advertising
Advertising expenditures
Computer and Information Sciences
Consumer advertising
Data processing
Drug Industry - statistics & numerical data
Drugs
Health care
Health Personnel - statistics & numerical data
Health Promotion - statistics & numerical data
Humans
Internet
Marketing
Medicine and Health Sciences
People and Places
Prescription drugs
Prescription Drugs - therapeutic use
Public health
Public Health - statistics & numerical data
Publications - statistics & numerical data
Regulatory agencies
Research and Analysis Methods
Social networks
Social Sciences
United States
United States Food and Drug Administration - statistics & numerical data
Web sites
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The volume of prescription drug promotion over time is often measured by assessing changes in ad spending. However, this method obscures the fact that some types of advertising are more expensive than others. Another way to measure the changes in prescription drug promotion over time is to assess the number of promotional pieces submitted to the U.S. Food and Drug Administration (FDA). Form FDA 2253 collects information such as the date submitted and the type of material submitted. We analyzed data from Forms FDA 2253 received from 2001-2014. We examined the frequency of submissions by audience (consumer and healthcare professional) and type of promotional material. There was a noted increase in prescription drug promotion submissions across all media in the early 2000s. Although non-Internet promotion submissions have since plateaued, Internet promotion continued to increase. These results can help public health advocates and regulators focus attention and resources.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0155035